Clinical Trial: CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Rotavirus Infections
Study Type: INTERVENTIONAL
Official Title: A Phase 1 Study to Evaluate the Safety and Immunogenicity of CDC-9 Inactivated Rotavirus Adjuvanted Vaccine for Intramuscular Administration in Healthy Adults
Brief Summary:
This is a study of CDC-9 inactivated rotavirus vaccine (IRV) for intramuscular administration (IM) in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series.The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.
Read more